相关实验视频

Updated: Jul 18, 2025

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

在PMM2-CDG中受损的细胞生物能学和自的相互作用

Anna N Ligezka¹, Rohit Budhraja², Yurika Nishiyama¹

¹Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA.

|August 26, 2023

概括

这项研究揭示了PMM2-CDG纤维细胞中二次线粒体功能障碍和改变的自性. 自可以调节疾病的严重程度,为这种复杂的遗传性疾病提供新的治疗点.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
遗传学遗传学是一个

背景情况:

血糖化 (CDG) 的先天性疾病和线粒体疾病共享重叠的症状.
在PMM2基因的致病变体导致异常的N-链接糖化,可能导致内质网膜压力和疾病.
虽然在一些CDG中注意到线粒体功能障碍,但其在PMM2-CDG中的详细作用仍未评估.

研究的目的:

研究PMM2-CDG患者衍生纤维细胞中的线粒体功能和自/线粒体功能.
探索PMM2-CDG中细胞生物能学,自和疾病严重程度标志物之间的关系.

主要方法:

在体外分析线粒体呼吸和电子运输链复合物I的功能.
评估自标志物,包括LC3-II丰度.
评估蛋白质丰富度和糖化在自和髓的途径.
血清索尔比托水平,CDG严重程度得分和LC3-II丰度之间的相关性分析.

主要成果:

PMM2-CDG纤维细胞表现出二次线粒体功能障碍,其特征是最大和ATP相关的呼吸减少,I复合体活动受损.
自细胞标记物LC3-II的增加表明PMM2-CDG.中自细胞的改变.
自和髓通路的失调进一步得到了蛋白质丰度和糖化酶的变化所支持.
血清比醇水平和CDG严重性得分与LC3-II丰度相反相关,这表明自的调节作用.

结论:

PMM2-CDG与二次线粒体功能障碍和失调的自/线粒体功能障碍有关.
自似乎调节PMM2-CDG中的生化和临床疾病严重程度.
准线粒体功能障碍和自/线粒体通路可能为PMM2-CDG提供治疗效益,补充现有治疗方法.

关键词:

在LC3-II自标志物中,自标志物是LC3-II.葡萄糖化先天性疾病.葡萄糖蛋白质组学药物线粒细胞衰变 (mitophagy) 是一种神经衰变的过程.胺转基因酶2缺乏症蛋白质组学蛋白质组学第二次次优的线粒体功能.

更多相关视频

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

Published on: November 22, 2017

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Autophagy

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Autophagic Cell Death

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...